2024
|
Invention
|
Immune repertoire patterns.
The present invention provides methods and systems for identifying a... |
|
Invention
|
Cleaved neoepitopes. The present invention relates to methods for treating, by administration of ... |
|
Invention
|
Expedited neoantigen vaccines. The present invention provides methods for evaluation of potential... |
2023
|
Invention
|
Tumor-associated antigens in brain tumors. The present invention relates to the identification an... |
|
Invention
|
Epitope mimics.
This invention pertains to the identification of antibody mediated epitope mimic... |
2022
|
Invention
|
Personalized allogeneic immunotherapy.
The present invention provides methods for treating cance... |
|
Invention
|
Personalized allogeneic immunotherapy. The present invention provides methods for treating cancer... |
2021
|
Invention
|
Formulation of peptide immunotherapies.
This invention provides a method for maximizing the immu... |
|
Invention
|
Administration of anti-tumor vaccines.
The present invention relates to methods for stimulating ... |
|
Invention
|
Bystander protein vaccines.
The present invention is related to T cell epitopes and methods of t... |
|
Invention
|
Bystander protein vaccines. The present invention is related to T cell epitopes and methods of th... |
|
Invention
|
Personalized immunotherapies. in vitro de novode novo peptides, or their encoding nucleic acids, ... |
|
Invention
|
Administration of anti-tumor vaccines. The present invention relates to methods for stimulating t... |
|
Invention
|
Bioinformatic processes for determination of peptide binding.
This invention relates to the iden... |
|
Invention
|
Mathematical processes for determination of peptidase cleavage.
This invention relates to the id... |
2020
|
Invention
|
Immune motifs in products from domestic animals.
The present invention provides a means to prepa... |
|
Invention
|
Immune recognition motifs.
The present invention provides methods and systems for identifying an... |
|
Invention
|
Bioinformatic processes for determination of peptide binding. This invention relates to the ident... |
|
Invention
|
Neoantigen immunotherapies.
This invention provides a method for maximizing the immune response ... |
|
Invention
|
Neoantigen immunotherapies. in vitro de novode novo peptides, or their encoding nucleic acids, ha... |
2019
|
Invention
|
Immune repertoire patterns. The present invention provides methods and systems for identifying an... |
2017
|
Invention
|
Epitope mimics. This invention pertains to the identification of antibody mediated epitope mimics... |
|
Invention
|
Modified zika virus ns1 protein with reduced cross-reactive immunogenicity. The present invention... |
|
Invention
|
Interventions for flavivirus infections. The present invention relates to vaccine compositions an... |
2015
|
Invention
|
Immunoglobulin polypeptide fractions from products of domestic animals. The present invention pro... |
|
Invention
|
Identifying peptides having t-cell-exposed motifs with known frequency of occurrence in a referen... |
|
Invention
|
Immune recognition motifs. The present invention provides methods and systems for identifying and... |
|
Invention
|
Immune motifs in products from domestic animals. The present invention provides a means to prepar... |
2014
|
Invention
|
Mathematical processes for determination of peptidase cleavage. This invention relates to the ide... |
|
Invention
|
Mathematical processes for determination of peptidase cleavage. The present invention provides a ... |
2013
|
Invention
|
Antimicrobial compositions.
The present invention relates antimicrobial compositions, and in par... |
|
Invention
|
Antimicrobial compositions. The present invention relates antimicrobial compositions, and in part... |
|
Invention
|
Targeted cryptosporidium biocides. The present invention relates to fusion proteins comprising a ... |
2011
|
Invention
|
Bioinformatic processes for determination of peptide binding. This invention relates to processes... |
|
Invention
|
Bioinformatic processes for determination of peptide binding. Methods of identification of peptid... |
2009
|
Invention
|
Targeted biocides.
The present invention relates to retroviral constructs that encode novel mono... |
2007
|
Invention
|
Immunoglobulin directed biocides.
The present invention relates to retroviral constructs that en... |
|
Invention
|
Innate immune receptor directed biocides.
The present invention relates to retroviral constructs... |
|
Invention
|
Antimicrobial peptide biocides.
The present invention relates to retroviral constructs that enco... |
2006
|
Invention
|
Targeted biocides. The present invention relates to retroviral constructs that encode novel... |
2005
|
Invention
|
Biocides.
The present invention relates to the use of biocide (e.g., bactericidal enzyme) to tar... |